Today news
About the same in other media
Lupin gets USFDA nod to market generic antifungal tablets
Reading now: 261
Lupin Ltd on Monday said it has received approval from the US health regulator to market its generic Fluconazole tablets used in the treatment of fungal infections. The approval granted by the US Food and Drug Administration (USFDA) for the abbreviated new drug application of Fluconazole tablets in strengths of 50 mg, 100 mg, 150 mg and 200 mg, Lupin said in a regulatory filing.
These are the generic equivalents of Diflucan tablets, 50 mg, 100 mg, 150 mg, and 200 mg, of Pfizer Inc, it added.
This product will be manufactured at Lupin's Pithampur facility in India, the company said.
About this in other media
Zydus and Lupin sign licensing agreement for co-marketing drug to treat chronic liver diseases in India financialexpress.com /1 year ago
Starbucks gets sales bump from strong US demand investing.com /1 year ago
'I guess you’re stuck with me now.' Sidhartha Mallya gets engaged to girlfriend Jasmine at Halloween party, announces life update on Instagram economictimes.indiatimes.com /1 year ago
Show more
The website fvbb.com is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.
